4th Edition of International Conference on Probiotics and Prebiotics
March 26-28, 2026
Preventive Probiotics and Prebiotics
Preventive probiotics and prebiotics are vital for sustaining optimal health and reducing the risk of future health issues. Probiotics help maintain microbial balance in the gut, preventing the overgrowth of harmful bacteria that can lead to digestive problems and infections. Regular consumption of probiotics has been linked to a reduced risk of developing gastrointestinal diseases, such as inflammatory bowel disease and irritable bowel syndrome. Prebiotics, by fostering the growth of beneficial gut bacteria, enhance immune function and promote overall digestive health. This combination offers a preventive strategy for managing chronic conditions, including metabolic disorders, cardiovascular disease, and autoimmune conditions, highlighting the long-term benefits of integrating probiotics and prebiotics into daily health routines.
Dipak P Ramji
Cardiff University, United Kingdom
Giuseppinella Melita
University of Study Messina, Italy
Jason Ryan
Sacco System, Australia
Najat Amharar
Burjeel, United Arab Emirates
Hazal Kibar Demirhan
Ankara University, Turkey
Euller Fernandes Lopes
University of Brasília, Brazil
Veronica Donato
Northeastern University, United StatesSubmit your abstract Today
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: State-of-the-art and new insights
Giuseppinella Melita, University of Study Messina, Italy
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey